Johnson Craig A
Insider CIK 1370348 · RDEA Director · MRTX Director · AUPH Director · ODT Director · HRTX Director · ADMP Director · LJPC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2026-06-04 | 2026-06-08 | 23,931 | — | $0 | 23,931 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2026-01-30 | 2026-02-03 | 53,960 | — | $0 | 53,960 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2025-11-21 | 2025-11-24 | 6,039 | $15.68 | $94.7K | 14,592 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2025-05-16 | 2025-05-16 | 37,485 | — | $0 | 37,485 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 35,900 | — | $0 | 35,900 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2025-01-31 | 2025-02-04 | 17,950 | — | $0 | 83,770 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-30 | 2025-02-03 | 35,900 | $1.73 | $62.1K | 35,900 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2025-01-30 | 2025-02-03 | 17,950 | — | $0 | 83,770 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2024-11-21 | 2024-11-25 | 31,688 | — | $0 | 31,688 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2024-11-21 | 2024-11-25 | 20,631 | — | $0 | 20,631 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 18,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 7,520 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 11,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,021 | — | $0 | 11,252 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 4,444 | — | $0 | 6,808 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,808 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 83,685 | — | $0 | 83,685 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2024-01-19 | 2024-01-19 | 13,948 | — | $0 | 65,820 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 6,808 | $58.75 | $400.0K | 17,273 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 7,520 | — | $0 | 7,520 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 4,444 | — | $0 | 10,465 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2022-12-16 | 2022-12-20 | 77,160 | — | $0 | 77,160 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2022-12-16 | 2022-12-20 | 38,580 | — | $0 | 51,872 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 12,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 10,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 10,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 10,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 10,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 19,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 30,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 30,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 30,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer deriv | 2022-08-22 | 2022-08-24 | 18,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | D To issuer | 2022-08-22 | 2022-08-24 | 12,000 | $6.23 | $74.8K | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | M Exercise deriv | 2022-07-08 | 2022-07-12 | 12,000 | — | $0 | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | M Exercise | 2022-07-08 | 2022-07-12 | 12,000 | $3.93 | $47.2K | 12,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 3,688 | — | $0 | 3,688 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 2,546 | — | $0 | 6,021 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2022-01-12 | 2022-01-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-12-22 | 2021-12-23 | 20,903 | — | $0 | 20,903 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2021-12-22 | 2021-12-23 | 10,452 | — | $0 | 13,292 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-12-21 | 2021-12-23 | 250 | $9.73 | $2.4K | 2,840 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-09-21 | 2021-09-23 | 250 | $12.30 | $3.1K | 3,090 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-06-21 | 2021-06-22 | 250 | $15.20 | $3.8K | 3,340 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-04-06 | 2021-04-07 | 250 | $17.22 | $4.3K | 3,590 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-01-21 | 2021-01-25 | 15,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 3,505 | $210.01 | $736.1K | 14,970 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-01-21 | 2021-01-25 | 15,000 | $20.54 | $308.1K | 18,475 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 3,183 | $210.81 | $671.0K | 11,787 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 4,562 | $211.94 | $966.9K | 7,225 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 3,372 | $212.97 | $718.1K | 3,853 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 44 | $213.62 | $9.4K | 3,809 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 334 | $214.75 | $71.7K | 3,475 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,155 | — | $0 | 2,155 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 1,475 | — | $0 | 3,475 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-29 | 2020-12-31 | 3,000 | $17.00 | $51.0K | 3,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-12-21 | 2020-12-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2020-12-21 | 2020-12-23 | 3,000 | — | $0 | 3,840 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2020-12-10 | 2020-12-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | A Award deriv | 2020-12-08 | 2020-12-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-04-20 | 2020-04-21 | 15,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-04-20 | 2020-04-21 | 15,000 | $93.00 | $1.40M | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-04-20 | 2020-04-21 | 15,000 | $25.84 | $387.6K | 17,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2020-01-09 | 2020-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 2,000 | — | $0 | 2,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2019-12-20 | 2019-12-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-12-19 | 2019-12-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | A Award deriv | 2019-12-10 | 2019-12-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-01-29 | 2019-01-31 | 7,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-01-29 | 2019-01-31 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-01-29 | 2019-01-31 | 7,000 | $15.79 | $110.5K | 7,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-01-29 | 2019-01-31 | 10,000 | $3.65 | $36.5K | 17,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-29 | 2019-01-31 | 8,475 | $61.11 | $517.9K | 8,525 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-29 | 2019-01-31 | 8,525 | $61.80 | $526.8K | 0 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2019-01-23 | 2019-01-28 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-01-17 | 2019-01-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | A Award deriv | 2018-12-31 | 2019-01-03 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2018-12-15 | 2018-12-18 | 21,000 | — | $0 | 21,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2018-01-18 | 2018-01-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | A Award deriv | 2018-01-02 | 2018-01-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-12-18 | 2017-12-20 | 21,000 | — | $0 | 21,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2017-12-11 | 2017-12-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2017-01-04 | 2017-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-12-21 | 2016-12-23 | 21,000 | — | $0 | 21,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-10-07 | 2016-10-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-06-22 | 2016-06-23 | 1,000 | — | $0 | 1,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2015-12-22 | 2015-12-24 | 19,000 | — | $0 | 19,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2015-12-21 | 2015-12-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2015-05-21 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2015-02-23 | 2015-02-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2014-12-12 | 2014-12-15 | 19,000 | — | $0 | 19,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-09-09 | 2014-09-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-09-09 | 2014-09-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2014-04-03 | 2014-04-07 | 13,000 | — | $0 | 13,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2014-04-03 | 2014-04-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LJPC LA JOLLA PHARMACEUTICAL CO | A Award deriv | 2013-11-21 | 2013-11-26 | 900,000 | — | $0 | 900,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2013-11-08 | 2013-11-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ADMP Adamis Pharmaceuticals Cor | A Award deriv | 2013-10-16 | 2013-10-17 | 0 | — | $0 | 0 | SEC↗ |
| ADMP Adamis Pharmaceuticals Cor | A Award | 2013-03-06 | 2013-03-12 | 22,575 | — | $0 | 22,575 | SEC↗ |
| ADMP Adamis Pharmaceuticals Cor | A Award deriv | 2012-10-11 | 2012-10-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 12,500 | $15.53 | $194.1K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 12,500 | $6.03 | $75.4K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 5,000 | $17.58 | $87.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 25,000 | $17.58 | $439.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 9,500 | $19.84 | $188.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 10,000 | $19.84 | $198.4K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 12,500 | $17.71 | $221.4K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | A Award deriv | 2012-01-03 | 2012-01-05 | 12,500 | — | $0 | 12,500 | SEC↗ |